## Abstract Mucopolysaccharidosis type IIIA (MPS IIIA) is a lysosomal storage disorder caused by a deficiency in sulphamidase (NS), a lysosomal enzyme required for the degradation of heparan sulphate glycosaminoglycans (gags). The MPS IIIA mouse is a naturally occurring model that accurately reflec
A type-token identity in the Simon-Yule model of text
โ Scribed by Chen, Ye-Sho ;Leimkuhler, Ferdinand F.
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 970 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0002-8231
No coin nor oath required. For personal study only.
โฆ Synopsis
There are three significant results in this paper. First, we establish a type-token identity relating the typetoken ratio and the biiogarithmic type-token ratio. The plays of Shakespeare and other interesting texts serve as demonstrative examples. Second, the Simon-Yule model of Zipf's law is used to derive the type-token identity and provide a promising statistical model of text generation. Third, a realistic refinement of the Simon-Yule model is made to allow for a decreasing entry rate of new words. Simulation methods are used to show that the type-token identity is preserved with this change in assumptions.
๐ SIMILAR VOLUMES
The damping effect in the motion of two bodies is investigated in the frame of the general theory of relativity. The solution for the field is chosen to approximate an outgoing wave at infinity. The components of the field are evaluated in the required orders of approximation by the EIH method. It i
Recent advances in evolutionary molecular engineering have revealed that the essential nature of a "virus" in the evolutionary aspect is its bonding strategy for assignment of the phenotype to its genotype. Based on the definition of "virus"-type and "cell"-type of the assignment strategy, we propos
## Abstract ## Objectives/Hypothesis: Human papillomavirus (HPV) types 6 and 11 are associated with recurrent respiratory papillomatosis (RRP). Although a prophylactic vaccine has been developed that protects against HPV infection, a therapeutic vaccine is still needed for those patients infected